280 related articles for article (PubMed ID: 15308351)
1. Bovine viral diarrhea virus with deletions in the 5'-nontranslated region: reduction of replication in calves and induction of protective immunity.
Makoschey B; Becher P; Janssen MG; Orlich M; Thiel HJ; Lütticken D
Vaccine; 2004 Sep; 22(25-26):3285-94. PubMed ID: 15308351
[TBL] [Abstract][Full Text] [Related]
2. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
Fairbanks K; Schnackel J; Chase CC
Vet Ther; 2003; 4(1):24-34. PubMed ID: 12756633
[TBL] [Abstract][Full Text] [Related]
4. Packaged replicons of bovine viral diarrhea virus are capable of inducing a protective immune response.
Reimann I; Semmler I; Beer M
Virology; 2007 Sep; 366(2):377-86. PubMed ID: 17544049
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves.
Salt JS; Thevasagayam SJ; Wiseman A; Peters AR
Vet J; 2007 Nov; 174(3):616-26. PubMed ID: 17276108
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with a modified-live bovine viral diarrhea virus (BVDV) type 1a vaccine completely protected calves against challenge with BVDV type 1b strains.
Xue W; Mattick D; Smith L; Umbaugh J; Trigo E
Vaccine; 2010 Dec; 29(1):70-6. PubMed ID: 21034829
[TBL] [Abstract][Full Text] [Related]
8. Evolution of bovine viral diarrhea virus vaccines.
Kelling CL
Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):115-29. PubMed ID: 15062478
[TBL] [Abstract][Full Text] [Related]
9. Genetic characterization of bovine viral diarrhea viruses isolated from persistently infected calves born to dams vaccinated against bovine viral diarrhea virus before breeding.
Bolin SR; Lim A; Grotelueschen DM; McBeth WW; Cortese VS
Am J Vet Res; 2009 Jan; 70(1):86-91. PubMed ID: 19119952
[TBL] [Abstract][Full Text] [Related]
10. Noncytopathic bovine viral diarrhea virus can persist in testicular tissue after vaccination of peri-pubertal bulls but prevents subsequent infection.
Givens MD; Riddell KP; Walz PH; Rhoades J; Harland R; Zhang Y; Galik PK; Brodersen BW; Cochran AM; Brock KV; Carson RL; Stringfellow DA
Vaccine; 2007 Jan; 25(5):867-76. PubMed ID: 17005300
[TBL] [Abstract][Full Text] [Related]
11. Response of cattle persistently infected with noncytopathic bovine viral diarrhea virus to vaccination for bovine viral diarrhea and to subsequent challenge exposure with cytopathic bovine viral diarrhea virus.
Bolin SR; McClurkin AW; Cutlip RC; Coria MF
Am J Vet Res; 1985 Dec; 46(12):2467-70. PubMed ID: 3002214
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of acetylethyleneimine-killed bovine viral diarrhea-mucosal disease virus (BVD) vaccine for prevention of BVD infection of the fetus.
McClurkin AW; Coria MF; Smith RL
Proc Annu Meet U S Anim Health Assoc; 1975; (79):114-23. PubMed ID: 220623
[No Abstract] [Full Text] [Related]
13. Suppression of bovine viral diarrhea virus replication by small interfering RNA and short hairpin RNA-mediated RNA interference.
Lambeth LS; Moore RJ; Muralitharan MS; Doran TJ
Vet Microbiol; 2007 Jan; 119(2-4):132-43. PubMed ID: 17052865
[TBL] [Abstract][Full Text] [Related]
14. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
[TBL] [Abstract][Full Text] [Related]
15. Novel BVDV-2 mutants as new candidates for modified-live vaccines.
Zemke J; König P; Mischkale K; Reimann I; Beer M
Vet Microbiol; 2010 Apr; 142(1-2):69-80. PubMed ID: 19875253
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of a temperature-sensitive bovine viral diarrhea vaccine strain.
Lobmann M; Charlier P; Florent G; Zygraich N
Am J Vet Res; 1984 Dec; 45(12):2498-503. PubMed ID: 6098205
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of bovine viral diarrhoea viruses from Australia.
Mahony TJ; McCarthy FM; Gravel JL; Corney B; Young PL; Vilcek S
Vet Microbiol; 2005 Mar; 106(1-2):1-6. PubMed ID: 15737468
[TBL] [Abstract][Full Text] [Related]
18. Point mutations in an infectious bovine viral diarrhoea virus type 2 cDNA transcript that yields an attenuated and protective viral progeny.
Dehan P; Couvreur B; Hamers C; Lewalle P; Thiry E; Kerkhofs P; Pastoret PP
Vaccine; 2005 Jul; 23(33):4236-46. PubMed ID: 16005739
[TBL] [Abstract][Full Text] [Related]
19. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
Platt R; Burdett W; Roth JA
Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of vaccination of seronegative bulls with modified-live, cytopathic bovine viral diarrhea viruses.
Givens MD; Riddell KP; Zhang Y; Galik P; Walz PH; Brodersen BW; Johnson JW; Passler T; Widel P; Tremblay R
Theriogenology; 2009 Apr; 71(6):975-83. PubMed ID: 19144395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
